Literature DB >> 2589104

Fatal poisonings with antidepressants in Finland 1985-1987.

E Vuori1, A Ruohonen, A Penttilä, T Klaukka, T Lahti.   

Abstract

In Finland the majority of the users of antidepressants are women and old age people. In the 80's the number of fatal poisonings has increased. During the years 1985-1987 58% of these poisonings were women who belonged to the younger age group of the users. The older tricyclic drugs are known to be more toxic, at least in overdose, than the newer antidepressants especially when they are compared to mianserin. Of the latter, however, lately more serious side effects have been reported. For this reason the use of the different kinds of antidepressants in Finland had changed: the sales of doxepin and amitriptyline have increased and those of maprotiline and mianserin have decreased. To study the role of antidepressants in sudden and unexpected deaths the fatality ratio (defined as fatalities divided by defined daily doses per 1000 inhabitants/day) was calculated for four most prescribed antidepressants. As to the sales, amitriptyline has to be considered to be the leading antidepressant followed by doxepin, mianserin and maprotiline. As a detection in the forensic toxicological screening the sales related ratios showed that maprotiline was most commonly found followed by doxepin, amitriptyline and mianserin. When an antidepressant was the cause of death the fatality ratio was highest for doxepin (6.4) followed by maprotiline (4.3), amitriptyline (4.0) and mianserin (1). In cases of established suicides the order was the same again.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589104     DOI: 10.1111/j.1600-0447.1989.tb03047.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  6 in total

1.  Prevalence of adverse drug combinations in a large post-mortem toxicology database.

Authors:  Terhi Launiainen; Erkki Vuori; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2008-06-27       Impact factor: 2.686

2.  Prevention of poststroke depression: 1 year randomised placebo controlled double blind trial of mianserin with 6 month follow up after therapy.

Authors:  H Palomäki; M Kaste; A Berg; R Lönnqvist; J Lönnqvist; M Lehtihalmes; J Hares
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

3.  Antidepressants and suicide.

Authors:  E Vuori; J Lönnqvist; T Klaukka
Journal:  BMJ       Date:  1994-06-11

4.  Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database.

Authors:  Ilkka Ojanperä; Pirkko Kriikku; Erkki Vuori
Journal:  Int J Legal Med       Date:  2016-03-17       Impact factor: 2.686

Review 5.  Epidemiology and relative toxicity of antidepressant drugs in overdose.

Authors:  J A Henry
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

Review 6.  Antidepressant toxicity and the need for identification and concentration monitoring in overdose.

Authors:  B M Power; L P Hackett; L J Dusci; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.